Progyny, Inc. (PGNY) Dividend History

Company News

• Progyny, Inc. Announces Details for Its First Quarter 2025 Results Report

  Progyny, Inc. (PGNY) will report its Q1 2025 financial results on May 8, 2025, and host a conference call to discuss the results.

  GlobeNewswire Inc.
• Progyny Tops EPS Forecast, Eyes Growth

  Progyny, a leading fertility benefits provider, reported strong Q4 2024 results, with revenue and adjusted EPS exceeding analyst estimates. However, the company faced setbacks, including the loss of a significant client, which affected its growth projection for 2025. Variability in member engagement remains a concern, and the company's future revenues and treatment utilization rates are less predictable.

  The Motley Fool
• The Law Offices of Frank R. Cruz Announces Investigation of Progyny, Inc. (PGNY) on Behalf of Investors

  Progyny, Inc. disclosed the loss of a significant client representing 12% of its revenue, causing a 32.7% drop in its stock price. The Law Offices of Frank R. Cruz is investigating the company for possible violations of federal securities laws.

  Benzinga
• JMP Securities initiates Progyny stock at 'Outperform' due to growth potential - Investing.com

  JMP Securities initiated coverage on Progyny, a company specializing in fertility benefits, with an 'Outperform' rating due to its growth potential. The firm set a price target of $36, citing Progyny's unique platform and strong performance with over 450 clients and 6 million members.

  Investing.com
• Enhabit (EHAB) Beats Q1 Earnings Estimates

  Enhabit (EHAB) delivered earnings and revenue surprises of 40% and 2.18%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: EHAB